Theravance Biopharma
TBPH
TBPH
108 hedge funds and large institutions have $882M invested in Theravance Biopharma in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 19
1% more funds holding
Funds holding: 107 → 108 (+1)
19% less capital invested
Capital invested by funds: $1.09B → $882M (-$210M)
Holders
108
Holding in Top 10
2
Calls
$1.45M
Puts
$838K
Top Buyers
| 1 | +$20.1M | |
| 2 | +$18.3M | |
| 3 | +$17.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1M |
Top Sellers
| 1 | -$24M | |
| 2 | -$3.63M | |
| 3 | -$2.43M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.19M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$1.91M |